Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

NCT03397862 is registered in ClinicalTrials.gov with Corium, Inc. as lead sponsor.

NCT NCT03397862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03397862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
Lead sponsor
Corium, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 14, 2017
Completion date
April 2, 2018
Enrollment
256 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sensitization, skin irritation